Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Captozyme
3150
Captozyme
Technology
Biotechnology
Captozyme is a preclinical stage biotechnology company dedicated to the enhancement of foods to reduce intake of oxalate.
Suggest edits
Founded
2009
Raised
$3.4M
Follow us
Companies in the same industry
Cytena
Caldan Therapeutics
REGEMAT3D
Knomics
NuLeaf Tech Inc
Chordia Therapeutics
Akouos
Lumen Bioscience, Inc.
Aeonian Pharmaceuticals
Inscripta, Inc.
Alexa global traffic share
Overview
Funding
1
Add info
Add round
15 Mar
2017
$3,400,000
Venture capital (Series A)
Captozyme Secures $3.4 Million to Continue Enzyme Research
prnewswire
